Antagonism of platelet-derived growth factor by perivascular gene transfer attenuates adventitial cell migration after vascular injury: new tricks for old dogs?

被引:18
作者
Mallawaarachchi, Chandike M.
Weissberg, Peter L.
Siow, Richard C. M.
机构
[1] Kings Coll London, Sch Biomed & Hlth Sci, Div Cardiovasc, London SE1 1UL, England
[2] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Div Cardiovasc Med, Cambridge, England
关键词
restenosis; vascular remodeling; balloon angioplasty; PDGF;
D O I
10.1096/fj.05-5435fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Migration of adventitial fibroblasts contributes to vascular remodeling after angioplasty. This study has used perivascular gene transfer of a truncated platelet-derived growth factor PDGF receptor (PDGFXR) to investigate whether antagonism of PDGF signaling alters adventitial cell migration after balloon injury in rat carotid arteries. Adenoviruses coordinating expression of beta-galactosidase (LacZ) and PDGFXR or LacZ and green fluorescent protein (GFP) were applied to the perivascular surface of arteries and balloon injury performed 4 days later. Vessels were excised at 3, 7, and 14 days to determine morphology and gene expression. Uninjured arteries only expressed LacZ positive cells in the adventitial compartment; however, after injury in LacZ and GFP transfected arteries, LacZ positive cells contributed to the population of cells within the media and neointima at 7-14 days. Overexpression of PDGFXR and LacZ resulted in a significant reduction in the number of LacZ labeled cells in the neointima after vascular injury, concomitant with reduced remodeling, collagen content, expression of matrix metalloproteinase-2, and increased levels of tissue inhibitors of metalloproteinase-1 and -2. We provide evidence that perivascular antagonism of PDGF attenuates remodeling and contribution of adventitial fibroblasts to neointima formation after balloon angioplasty. Perivascular gene transfer may represent a therapeutic strategy to reduce the incidence of restenosis.
引用
收藏
页码:1686 / +
页数:8
相关论文
共 30 条
[1]   Chimera analysis supports a predominant role of PDGFRβ in promoting smooth-muscle cell chemotaxis after arterial injury [J].
Buetow, BS ;
Tappan, KA ;
Crosby, JR ;
Seifert, RA ;
Bowen-Pope, DF .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (03) :979-984
[2]   Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II [J].
Choi, MH ;
Lee, IK ;
Kim, GW ;
Kim, BU ;
Han, YH ;
Yu, DY ;
Park, HS ;
Kim, KY ;
Lee, JS ;
Choi, CH ;
Bae, YS ;
Lee, BI ;
Rhee, SG ;
Kang, SW .
NATURE, 2005, 435 (7040) :347-353
[3]   Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury [J].
Deguchi, J ;
Namba, T ;
Hamada, H ;
Nakaoka, T ;
Abe, J ;
Sato, O ;
Miyata, T ;
Makuuchi, M ;
Kurokawa, K ;
Takuwa, Y .
GENE THERAPY, 1999, 6 (06) :956-965
[4]   Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery [J].
Dourron, HM ;
Jacobson, GM ;
Park, JL ;
Liu, JH ;
Reddy, DJ ;
Scheel, ML ;
Pagano, PJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 288 (02) :H946-H953
[5]  
DUAN DSR, 1991, J BIOL CHEM, V266, P413
[6]   INHIBITION OF NEOINTIMAL SMOOTH-MUSCLE ACCUMULATION AFTER ANGIOPLASTY BY AN ANTIBODY TO PDGF [J].
FERNS, GAA ;
RAINES, EW ;
SPRUGEL, KH ;
MOTANI, AS ;
REIDY, MA ;
ROSS, R .
SCIENCE, 1991, 253 (5024) :1129-1132
[7]   Matrix metalloproteinases in vascular remodeling and atherogenesis - The good, the bad, and the ugly [J].
Galis, ZS ;
Khatri, JJ .
CIRCULATION RESEARCH, 2002, 90 (03) :251-262
[8]   Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice [J].
Hu, YH ;
Zhang, ZY ;
Torsney, E ;
Afzal, AR ;
Davison, F ;
Metzler, B ;
Xu, QB .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (09) :1258-1265
[9]   Platelet-derived growth factor activates production of reactive oxygen species by NAD(P)H-oxidase in smooth muscle cells through Gi1,2 [J].
Kreuzer, J ;
Viedt, C ;
Brandes, RP ;
Seeger, F ;
Rosenkranz, AS ;
Sauer, H ;
Babich, A ;
Nürnberg, B ;
Kather, H ;
Krieger-Brauer, HI .
FASEB JOURNAL, 2002, 16 (13) :38-+
[10]   Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support [J].
Lambiase, PD ;
Edwards, RJ ;
Anthopoulos, P ;
Rahman, S ;
Meng, YG ;
Bucknall, CA ;
Redwood, SR ;
Pearson, JD ;
Marber, MS .
CIRCULATION, 2004, 109 (24) :2986-2992